| 1.13 0.1 (9.71%) | 03-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.34 |
1-year : | 1.56 |
| Resists | First : | 1.14 |
Second : | 1.34 |
| Pivot price | 1.01 |
|||
| Supports | First : | 1 |
Second : | 0.92 |
| MAs | MA(5) : | 1.06 |
MA(20) : | 1.01 |
| MA(100) : | 0.97  |
MA(250) : | 1.21 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 59.4 |
D(3) : | 55.5 |
| RSI | RSI(14): 64.8 |
|||
| 52-week | High : | 2.86 | Low : | 0.62 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ADGM ] has closed above the upper band by 11.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 43.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 52 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.14 - 1.15 | 1.15 - 1.15 |
| Low: | 1.04 - 1.04 | 1.04 - 1.05 |
| Close: | 1.12 - 1.13 | 1.13 - 1.14 |
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Sat, 21 Mar 2026
If You Invested $1,000 in Adagio Medical (ADGM) - Stock Titan
Thu, 19 Mar 2026
13 hard-to-treat heart-rhythm patients received Adagio’s therapy - Stock Titan
Wed, 18 Mar 2026
Adagio Medical Holdings, Inc.: Fundamental Analysis and Financial Ratings | ADGM | US00534B1008 - marketscreener.com
Wed, 11 Mar 2026
Adagio Medical to meet investors at 38th Annual Roth Conference - Stock Titan
Tue, 24 Feb 2026
10 Best Up and Coming Penny Stocks to Buy - Insider Monkey
Tue, 24 Feb 2026
Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 3.78e+006 (%) |
| Held by Institutions | 2.5 (%) |
| Shares Short | 58 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.562e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -19 % |
| Return on Assets (ttm) | 543.7 % |
| Return on Equity (ttm) | -24.2 % |
| Qtrly Rev. Growth | 137000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -1502.58 |
| EBITDA (p.s.) | -1.43571e+007 |
| Qtrly Earnings Growth | -2.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | -1.76 |
| Dividend | 0 |
| Forward Dividend | 74410 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|